Healthtech Startups

SweetSpot provides a remote diabetes monitoring and management platform that improves data accessibility for clinicians and supports patients using diabetes technology such as CGMs and insulin pumps. It serves diabetes care providers and patients in the digital health space.

2 investors

Swiftsure Innovations develops medical devices for oral care, including the SwishKit, aimed at improving oral care for mechanically ventilated patients. Its products are designed for nurses and clinicians in critical care settings.

2 investors

Switchboard Health provides software that modernizes the specialty care referral process, using data sets, a virtual care network, and matching algorithms to connect patients with specialty care options. Its EMR-integrated tools serve care navigation teams, providers, and employers seeking to reduce specialty care costs while tracking the speed and quality of care.

2 investors

Sword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials. The company specializes in pharmacokinetics, biomarker analysis, and immunogenicity assessment for large molecule, gene therapy, and cell therapy biotherapeutics.

2 investors

Symbiome develops skin microbiome-based wellness products that restore ancestral skin health through proprietary fermentation and Amazonian botanical ingredients. The company targets consumers seeking reparative skincare solutions that address modern skin degradation through microbiome restoration.

2 investors

Symeres provides pharmaceutical quality management systems, drug discovery and development services, and contract manufacturing support for biotech and pharma companies. The company operates GMP, GLP, and ISO-certified facilities across Europe and North America to support molecules from early discovery through regulatory submission and manufacturing.

2 investors

Synakis develops ocular biomaterials, including its lead candidate SNK-125, through pre-clinical research and a pipeline of eye-related products. The company operates in the ophthalmic biomaterial and biotech space.

2 investors

Synapse Biomedical develops and commercializes neurostimulation medical devices, including the NeuRx Diaphragm Pacing System (DPS), which uses electrical stimulation of the diaphragm to treat chronic respiratory insufficiency in patients with spinal cord injuries and ALS. The company serves clinicians and patients dependent on mechanical ventilation.

2 investors

Synapsica Healthcare develops artificial intelligence software to automate diagnostic imaging analysis and report generation for radiologists and medical facilities.

2 investors

Synapsor manufactures a continuous glucose monitoring (CGM) system designed for diabetes patients. The wearable device tracks blood glucose levels in real time via a smartphone app and includes an AI assistant for personalized glucose management support.

2 investors

Syndi (HealthKey) operates a platform that gives organisations access to around 75 vetted healthcare providers, letting employers and insurers offer employees and customers services like therapy, physiotherapy, nutrition and at-home testing. The product can be branded to the client and is used by companies to deliver health and wellbeing benefits.

2 investors

Synergy Disc is a medical device company developing motion-preserving spine technologies to treat degenerative disc disease while supporting the spine's natural curvature. Its products serve patients undergoing spine surgery, in the spinal implant and medical device category.

2 investors

Building new drugs to target inflammation using an AI + immunology discovery engine.

2 investors

SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.

2 investors

SynThera develops bioactive glass-based biomaterials and specialty glass products for healthcare, industrial, and consumer applications including bone tissue regeneration, dental repair, skincare, and technical glass for electronics and aerospace. The company serves pharmaceutical, medical device, cosmetics, FMCG, and industrial sectors with a focus on high-purity glass materials.

2 investors

SynVaccine develops technology for the computer-aided design and construction of viral genomes, applying synthetic and computational biology to create viral-based products such as vaccines and viral-based therapeutics. The company targets applications in human pharma and animal health.

2 investors

Syremis Therapeutics is a clinical-stage biopharmaceutical company developing neuropsychiatric medicines based on mechanisms including muscarinic M1/M4 agonism and NMDA antagonism. Its pipeline includes ST-905, a dual M1/M4 agonist in Phase 1 for schizophrenia, and ST-901, an NMDA antagonist in IND-enabling studies for major depressive disorder and bipolar depression.

2 investors

T-CURX is a venture-backed biotechnology company developing autologous CAR-T cell therapies using proprietary non-viral technologies, including in vivo and bedside-manufactured CAR-T approaches based on T cell-targeted LNP delivery of Sleeping Beauty transposon vectors. Its clinical pipeline targets cancers such as AML and CLL as well as cross-entity targets in hematological malignancies and solid tumors.

2 investors

Tactile Orthopaedics develops high-fidelity surgical simulation models for orthopedic training, including knee arthroscopy simulators validated for surgical skill development. The company serves orthopedic surgeons and surgical training programs in medical education.

2 investors

Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients. The company leverages innovative methods in T cell engineering and gene therapy to address metastatic and gynecological cancers.

2 investors

Tailor Bio develops targeted cancer therapies for tumors characterized by chromosomal instability, working in the field of precision oncology.

2 investors

TailorCare provides personalized specialty care for patients with musculoskeletal (MSK) conditions such as joint, back, and muscle pain, guiding them toward appropriate treatment plans. The company focuses on improving care journeys and health outcomes for MSK patients in the United States.

2 investors

Tangible Science develops contact lens solutions designed to improve comfort and durability for wearers and to provide eye care professionals with more effective treatment options. The company serves contact lens wearers, optometrists, ophthalmologists, and lens manufacturers.

2 investors

TareBio operates a platform for developing personalized and population-level vaccines against cancer and infectious diseases by analyzing immune cells already responding to a disease and reverse-engineering the antigens that activate them. The company works in the biotechnology and vaccine development space.

2 investors